Avril Mansfield: Does Walking Asymmetry After Stroke Increase the Risk of Lateral Instability and Falls?
Avril Mansfield, Senior Scientist at Toronto Rehabilitation Institute, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”People who have had a stroke often walk asymmetrically, but provided they can walk fast enough and long enough to complete daily activities, does it matter?
One possible problem is that asymmetry is related to lateral instability.
Rowan Staines looked at the relationship between gait asymmetry and lateral instability in people with sub-acute stroke.
She found that people who walked asymmetrically tended to be more unstable towards their less affected side, increasing the risk of losing balance and falling to that side.
Our previous research found that people who have had a stroke are also less able to take reactive steps with the more affected side, so falling toward the less affected side could be particularly challenging for recovering balance and avoiding falling.”
Title: The relationship between gait asymmetry and stability in people with sub-acute stroke
Authors: Rowan Staines, Kara Patterson, David Jagroop, Elizabeth Inness, Avril Mansfield
Read the Full Article on medRxiv
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children